Your browser doesn't support javascript.
loading
Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria.
Maurer, Marcus; Berger, William; Giménez-Arnau, Ana; Hayama, Koremasa; Jain, Vipul; Reich, Adam; Haemmerle, Sibylle; Lheritier, Karine; Walsh, Pauline; Xia, Summer; Storim, Julian.
Afiliación
  • Maurer M; Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, Germany. Electronic address: Ma
  • Berger W; Southern California Research, Mission Viejo, Calif.
  • Giménez-Arnau A; Dermatology Department, Hospital del Mar-Parc de Salut Mar, UCARE, IMIM, Universitat Pompeu Fabra, Barcelona, Spain.
  • Hayama K; Division of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan.
  • Jain V; Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario.
  • Reich A; Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszów University, Rzeszów, Poland.
  • Haemmerle S; Novartis Pharma AG, Basel, Switzerland.
  • Lheritier K; Novartis Pharma AG, Basel, Switzerland.
  • Walsh P; Novartis Ireland Limited, Dublin, Ireland.
  • Xia S; Shanghai Novartis Trading Limited, Shanghai, China.
  • Storim J; Novartis Pharma AG, Basel, Switzerland.
J Allergy Clin Immunol ; 150(6): 1498-1506.e2, 2022 12.
Article en En | MEDLINE | ID: mdl-36096203
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Urticaria Crónica Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Urticaria Crónica Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos